Fox Chase Cancer Center News

PHILADELPHIA (June 12, 2018) — Fox Chase Cancer Center will celebrate the opening of its new outpatient oncology facility in East Norriton, Pennsylvania with a ribbon cutting ceremony and reception on June 15.

PHILADELPHIA (June 5, 2018) – Jennifer Barsky Reese, PhD, assistant professor in the Cancer Prevention and Control Program at Fox Chase Cancer Center, was selected by the Academy of Communication in Healthcare (ACH) to join the second cohort of the Putnam Scholars Program.

 In addition to their duties caring for patients, many Fox Chase Cancer Center staff volunteer their time to those most in need. Recently, two nurses and a doctor made a volunteer medical trip to Haiti, where they provided an array of medical services to those in desperate need of care.

PHILADELPHIA (June 4, 2018) – Early stage breast cancer patients undergoing chemotherapy may find that a text messaging-based intervention helps alleviate some of the dreaded side effects of treatment.

PHILADELPHIA (June 4, 2018) – A new study from Fox Chase Cancer Center shows that liquid biopsy can be a valuable tool in assessing patients’ progress throughout treatment for colorectal cancer. Researchers found that administering the blood test at intervals to search for circulating tumor cells or DNA in conjunction with current diagnostic tests can provide information that will help physicians adjust treatment decisions. 

PHILADELPHIA (June 2, 2018) – In recent years the Food and Drug Administration has approved several new drugs for men with newly diagnosed metastatic prostate cancer. A new study compares the cost-effectiveness of intravenous docetaxel (DC) and daily pill abiraterone acetate plus prednisone (AAP) and analyzes progression free and overall survival for each.

PHILADELPHIA (June 1, 2018) – National Cancer Survivors Day is June 3rd. Fox Chase Cancer Center is celebrating the lives of cancer survivors across the country. According to the National Cancer Institute, the term “cancer survivor” refers to any person with a history of cancer, from the time of diagnosis through the remainder of their life.

PHILADELPHIA (May 30, 2018) – Scientists seeking a path to better patient outcomes in ovarian cancer have discovered that a scaffolding protein known to promote breast cancer and melanoma metastasis, but aid in suppressing hematologic cancers, is associated with aggressive ovarian tumor growth.